CBP 1011: Colirest™, Hematrol™

Author： Limited A.I.  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.4, Iss.4, 2003-01, pp. : 241-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Avasimibe: CI 1011

By  

Drugs in R&D, Vol. 3, Iss. 3, 2002-01 ,pp. : 173-174

Adis International

Access to resources Recommend Favorite

Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders

By  

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5051-5064

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists

By  

Current Molecular Pharmacology, Vol. 11, Iss. 2, 2018-04 ,pp. : 113-121

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 4, 2018-01 ,pp. : 296-309

Bentham Science Publishers

Access to resources Recommend Favorite

Hypoxia Selects for a Quiescent, CML Stem/Leukemia Initiating- Like Population Dependent on CBP/Catenin Transcription

By  

Current Molecular Pharmacology, Vol. 6, Iss. 3, 2013-11 ,pp. : 204-210

Bentham Science Publishers

Access to resources Recommend Favorite